English
简体中文
Total: £ 56.28
Published Date: 2025-04-08 | Pages: 135 | Tables: 147 | Pharma & Healthcare
The global market for Calming Aids for Dogs was valued at US$ 532 million in the year 2024 and is projected to reach a revised size of US$ 845 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Canine sedatives refer to a class of drugs specifically used for canines, which are intended to calm, soothe or reduce anxiety through drug effects. Such drugs are usually used in veterinary clinical practice to help dogs stay calm during surgery, examination, treatment or specific stressful situations (such as travel, thunderstorm phobia, separation anxiety, etc.), reduce tension, fear or aggressive behavior, thereby ensuring the smooth progress of medical operations or improving animal welfare.
The market for canine sedatives has shown a steady growth trend in recent years, mainly benefiting from the booming pet economy and the significant increase in pet owners' attention to pet health and welfare. With the acceleration of urbanization and the improvement of people's living standards, the number of pet-raising families is increasing. As one of the most common pets, dogs have increasingly diversified medical needs, especially the use of sedatives, including surgical anesthesia assistance, behavior correction, travel comfort, etc. Current market dynamics show that technological innovation is the key to driving the development of the industry. The research and development of new sedatives focuses on safer, more efficient, and low-side effect products, such as drugs based on natural ingredients or targeted mechanisms of action, to meet the market's demand for pet-friendly medical solutions. At the same time, the strengthening of regulatory supervision has prompted companies to pay more attention to product quality and compliance, while the expansion of online sales channels and the digital transformation of pet medical services have also brought new growth points to the dog sedative market. It is expected that in the next few years, with the continued expansion of the pet medical market and the deepening of consumer awareness, the dog sedative market will maintain steady growth and develop in a more professional and refined direction.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Calming Aids for Dogs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calming Aids for Dogs.
The Calming Aids for Dogs market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Calming Aids for Dogs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Calming Aids for Dogs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
VetriScience
H&H Group
Vetoquinol
ThunderEase
Maxxidog
Heavenly Hounds
ElleVet Sciences
Wild One
FOMO Bones
Ark Naturals
Purina
Kradle
Zoetis
Pet Remedy
Ceva
Adaptil
Primo Pup
Penelope's Bloom
Extract Labs
Koi CBD
Elanco
Zatural
The Anxious Pet
This Dog's Life
NaturVet
King Kanine
Dr. Harvey’s
PetHonesty
Merck Animal Health
Boehringer Ingelheim
Shangrao Chunyu Technology
Shandong Youmi Le Health Technology
Segment by Type
Calming Supplements
Pheromone Sprays
Calming Collars
Anxiety Vests
Segment by Application
Household
Pet Hospitals and Clinics
Pet Shop
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Calming Aids for Dogs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Calming Aids for Dogs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Calming Aids for Dogs Market Overview
1.1 Product Definition
1.2 Calming Aids for Dogs by Type
1.2.1 Global Calming Aids for Dogs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Calming Supplements
1.2.3 Pheromone Sprays
1.2.4 Calming Collars
1.2.5 Anxiety Vests
1.3 Calming Aids for Dogs by Application
1.3.1 Global Calming Aids for Dogs Market Value by Application (2024 VS 2031)
1.3.2 Household
1.3.3 Pet Hospitals and Clinics
1.3.4 Pet Shop
1.3.5 Others
1.4 Global Calming Aids for Dogs Market Size Estimates and Forecasts
1.4.1 Global Calming Aids for Dogs Revenue 2020-2031
1.4.2 Global Calming Aids for Dogs Sales 2020-2031
1.4.3 Global Calming Aids for Dogs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Calming Aids for Dogs Market Competition by Manufacturers
2.1 Global Calming Aids for Dogs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Calming Aids for Dogs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Calming Aids for Dogs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Calming Aids for Dogs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Calming Aids for Dogs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Calming Aids for Dogs, Product Type & Application
2.7 Global Key Manufacturers of Calming Aids for Dogs, Date of Enter into This Industry
2.8 Global Calming Aids for Dogs Market Competitive Situation and Trends
2.8.1 Global Calming Aids for Dogs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Calming Aids for Dogs Players Market Share by Revenue
2.8.3 Global Calming Aids for Dogs Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Calming Aids for Dogs Market Scenario by Region
3.1 Global Calming Aids for Dogs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Calming Aids for Dogs Sales by Region: 2020-2031
3.2.1 Global Calming Aids for Dogs Sales by Region: 2020-2025
3.2.2 Global Calming Aids for Dogs Sales by Region: 2026-2031
3.3 Global Calming Aids for Dogs Revenue by Region: 2020-2031
3.3.1 Global Calming Aids for Dogs Revenue by Region: 2020-2025
3.3.2 Global Calming Aids for Dogs Revenue by Region: 2026-2031
3.4 North America Calming Aids for Dogs Market Facts & Figures by Country
3.4.1 North America Calming Aids for Dogs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Calming Aids for Dogs Sales by Country (2020-2031)
3.4.3 North America Calming Aids for Dogs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Calming Aids for Dogs Market Facts & Figures by Country
3.5.1 Europe Calming Aids for Dogs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Calming Aids for Dogs Sales by Country (2020-2031)
3.5.3 Europe Calming Aids for Dogs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Calming Aids for Dogs Market Facts & Figures by Region
3.6.1 Asia Pacific Calming Aids for Dogs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Calming Aids for Dogs Sales by Region (2020-2031)
3.6.3 Asia Pacific Calming Aids for Dogs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Calming Aids for Dogs Market Facts & Figures by Country
3.7.1 Latin America Calming Aids for Dogs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Calming Aids for Dogs Sales by Country (2020-2031)
3.7.3 Latin America Calming Aids for Dogs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Calming Aids for Dogs Market Facts & Figures by Country
3.8.1 Middle East and Africa Calming Aids for Dogs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Calming Aids for Dogs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Calming Aids for Dogs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Calming Aids for Dogs Sales by Type (2020-2031)
4.1.1 Global Calming Aids for Dogs Sales by Type (2020-2025)
4.1.2 Global Calming Aids for Dogs Sales by Type (2026-2031)
4.1.3 Global Calming Aids for Dogs Sales Market Share by Type (2020-2031)
4.2 Global Calming Aids for Dogs Revenue by Type (2020-2031)
4.2.1 Global Calming Aids for Dogs Revenue by Type (2020-2025)
4.2.2 Global Calming Aids for Dogs Revenue by Type (2026-2031)
4.2.3 Global Calming Aids for Dogs Revenue Market Share by Type (2020-2031)
4.3 Global Calming Aids for Dogs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Calming Aids for Dogs Sales by Application (2020-2031)
5.1.1 Global Calming Aids for Dogs Sales by Application (2020-2025)
5.1.2 Global Calming Aids for Dogs Sales by Application (2026-2031)
5.1.3 Global Calming Aids for Dogs Sales Market Share by Application (2020-2031)
5.2 Global Calming Aids for Dogs Revenue by Application (2020-2031)
5.2.1 Global Calming Aids for Dogs Revenue by Application (2020-2025)
5.2.2 Global Calming Aids for Dogs Revenue by Application (2026-2031)
5.2.3 Global Calming Aids for Dogs Revenue Market Share by Application (2020-2031)
5.3 Global Calming Aids for Dogs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 VetriScience
6.1.1 VetriScience Company Information
6.1.2 VetriScience Description and Business Overview
6.1.3 VetriScience Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 VetriScience Calming Aids for Dogs Product Portfolio
6.1.5 VetriScience Recent Developments/Updates
6.2 H&H Group
6.2.1 H&H Group Company Information
6.2.2 H&H Group Description and Business Overview
6.2.3 H&H Group Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 H&H Group Calming Aids for Dogs Product Portfolio
6.2.5 H&H Group Recent Developments/Updates
6.3 Vetoquinol
6.3.1 Vetoquinol Company Information
6.3.2 Vetoquinol Description and Business Overview
6.3.3 Vetoquinol Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Vetoquinol Calming Aids for Dogs Product Portfolio
6.3.5 Vetoquinol Recent Developments/Updates
6.4 ThunderEase
6.4.1 ThunderEase Company Information
6.4.2 ThunderEase Description and Business Overview
6.4.3 ThunderEase Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ThunderEase Calming Aids for Dogs Product Portfolio
6.4.5 ThunderEase Recent Developments/Updates
6.5 Maxxidog
6.5.1 Maxxidog Company Information
6.5.2 Maxxidog Description and Business Overview
6.5.3 Maxxidog Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Maxxidog Calming Aids for Dogs Product Portfolio
6.5.5 Maxxidog Recent Developments/Updates
6.6 Heavenly Hounds
6.6.1 Heavenly Hounds Company Information
6.6.2 Heavenly Hounds Description and Business Overview
6.6.3 Heavenly Hounds Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Heavenly Hounds Calming Aids for Dogs Product Portfolio
6.6.5 Heavenly Hounds Recent Developments/Updates
6.7 ElleVet Sciences
6.7.1 ElleVet Sciences Company Information
6.7.2 ElleVet Sciences Description and Business Overview
6.7.3 ElleVet Sciences Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ElleVet Sciences Calming Aids for Dogs Product Portfolio
6.7.5 ElleVet Sciences Recent Developments/Updates
6.8 Wild One
6.8.1 Wild One Company Information
6.8.2 Wild One Description and Business Overview
6.8.3 Wild One Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Wild One Calming Aids for Dogs Product Portfolio
6.8.5 Wild One Recent Developments/Updates
6.9 FOMO Bones
6.9.1 FOMO Bones Company Information
6.9.2 FOMO Bones Description and Business Overview
6.9.3 FOMO Bones Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 FOMO Bones Calming Aids for Dogs Product Portfolio
6.9.5 FOMO Bones Recent Developments/Updates
6.10 Ark Naturals
6.10.1 Ark Naturals Company Information
6.10.2 Ark Naturals Description and Business Overview
6.10.3 Ark Naturals Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ark Naturals Calming Aids for Dogs Product Portfolio
6.10.5 Ark Naturals Recent Developments/Updates
6.11 Purina
6.11.1 Purina Company Information
6.11.2 Purina Description and Business Overview
6.11.3 Purina Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Purina Calming Aids for Dogs Product Portfolio
6.11.5 Purina Recent Developments/Updates
6.12 Kradle
6.12.1 Kradle Company Information
6.12.2 Kradle Description and Business Overview
6.12.3 Kradle Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Kradle Calming Aids for Dogs Product Portfolio
6.12.5 Kradle Recent Developments/Updates
6.13 Zoetis
6.13.1 Zoetis Company Information
6.13.2 Zoetis Description and Business Overview
6.13.3 Zoetis Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Zoetis Calming Aids for Dogs Product Portfolio
6.13.5 Zoetis Recent Developments/Updates
6.14 Pet Remedy
6.14.1 Pet Remedy Company Information
6.14.2 Pet Remedy Description and Business Overview
6.14.3 Pet Remedy Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Pet Remedy Calming Aids for Dogs Product Portfolio
6.14.5 Pet Remedy Recent Developments/Updates
6.15 Ceva
6.15.1 Ceva Company Information
6.15.2 Ceva Description and Business Overview
6.15.3 Ceva Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Ceva Calming Aids for Dogs Product Portfolio
6.15.5 Ceva Recent Developments/Updates
6.16 Adaptil
6.16.1 Adaptil Company Information
6.16.2 Adaptil Description and Business Overview
6.16.3 Adaptil Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Adaptil Calming Aids for Dogs Product Portfolio
6.16.5 Adaptil Recent Developments/Updates
6.17 Primo Pup
6.17.1 Primo Pup Company Information
6.17.2 Primo Pup Description and Business Overview
6.17.3 Primo Pup Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Primo Pup Calming Aids for Dogs Product Portfolio
6.17.5 Primo Pup Recent Developments/Updates
6.18 Penelope's Bloom
6.18.1 Penelope's Bloom Company Information
6.18.2 Penelope's Bloom Description and Business Overview
6.18.3 Penelope's Bloom Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Penelope's Bloom Calming Aids for Dogs Product Portfolio
6.18.5 Penelope's Bloom Recent Developments/Updates
6.19 Extract Labs
6.19.1 Extract Labs Company Information
6.19.2 Extract Labs Description and Business Overview
6.19.3 Extract Labs Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Extract Labs Calming Aids for Dogs Product Portfolio
6.19.5 Extract Labs Recent Developments/Updates
6.20 Koi CBD
6.20.1 Koi CBD Company Information
6.20.2 Koi CBD Description and Business Overview
6.20.3 Koi CBD Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Koi CBD Calming Aids for Dogs Product Portfolio
6.20.5 Koi CBD Recent Developments/Updates
6.21 Elanco
6.21.1 Elanco Company Information
6.21.2 Elanco Description and Business Overview
6.21.3 Elanco Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Elanco Calming Aids for Dogs Product Portfolio
6.21.5 Elanco Recent Developments/Updates
6.22 Zatural
6.22.1 Zatural Company Information
6.22.2 Zatural Description and Business Overview
6.22.3 Zatural Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Zatural Calming Aids for Dogs Product Portfolio
6.22.5 Zatural Recent Developments/Updates
6.23 The Anxious Pet
6.23.1 The Anxious Pet Company Information
6.23.2 The Anxious Pet Description and Business Overview
6.23.3 The Anxious Pet Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.23.4 The Anxious Pet Calming Aids for Dogs Product Portfolio
6.23.5 The Anxious Pet Recent Developments/Updates
6.24 This Dog's Life
6.24.1 This Dog's Life Company Information
6.24.2 This Dog's Life Description and Business Overview
6.24.3 This Dog's Life Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.24.4 This Dog's Life Calming Aids for Dogs Product Portfolio
6.24.5 This Dog's Life Recent Developments/Updates
6.25 NaturVet
6.25.1 NaturVet Company Information
6.25.2 NaturVet Description and Business Overview
6.25.3 NaturVet Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.25.4 NaturVet Calming Aids for Dogs Product Portfolio
6.25.5 NaturVet Recent Developments/Updates
6.26 King Kanine
6.26.1 King Kanine Company Information
6.26.2 King Kanine Description and Business Overview
6.26.3 King Kanine Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.26.4 King Kanine Calming Aids for Dogs Product Portfolio
6.26.5 King Kanine Recent Developments/Updates
6.27 Dr. Harvey’s
6.27.1 Dr. Harvey’s Company Information
6.27.2 Dr. Harvey’s Description and Business Overview
6.27.3 Dr. Harvey’s Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Dr. Harvey’s Calming Aids for Dogs Product Portfolio
6.27.5 Dr. Harvey’s Recent Developments/Updates
6.28 PetHonesty
6.28.1 PetHonesty Company Information
6.28.2 PetHonesty Description and Business Overview
6.28.3 PetHonesty Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.28.4 PetHonesty Calming Aids for Dogs Product Portfolio
6.28.5 PetHonesty Recent Developments/Updates
6.29 Merck Animal Health
6.29.1 Merck Animal Health Company Information
6.29.2 Merck Animal Health Description and Business Overview
6.29.3 Merck Animal Health Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.29.4 Merck Animal Health Calming Aids for Dogs Product Portfolio
6.29.5 Merck Animal Health Recent Developments/Updates
6.30 Boehringer Ingelheim
6.30.1 Boehringer Ingelheim Company Information
6.30.2 Boehringer Ingelheim Description and Business Overview
6.30.3 Boehringer Ingelheim Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.30.4 Boehringer Ingelheim Calming Aids for Dogs Product Portfolio
6.30.5 Boehringer Ingelheim Recent Developments/Updates
6.31 Shangrao Chunyu Technology
6.31.1 Shangrao Chunyu Technology Company Information
6.31.2 Shangrao Chunyu Technology Description and Business Overview
6.31.3 Shangrao Chunyu Technology Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.31.4 Shangrao Chunyu Technology Calming Aids for Dogs Product Portfolio
6.31.5 Shangrao Chunyu Technology Recent Developments/Updates
6.32 Shandong Youmi Le Health Technology
6.32.1 Shandong Youmi Le Health Technology Company Information
6.32.2 Shandong Youmi Le Health Technology Description and Business Overview
6.32.3 Shandong Youmi Le Health Technology Calming Aids for Dogs Sales, Revenue and Gross Margin (2020-2025)
6.32.4 Shandong Youmi Le Health Technology Calming Aids for Dogs Product Portfolio
6.32.5 Shandong Youmi Le Health Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Calming Aids for Dogs Industry Chain Analysis
7.2 Calming Aids for Dogs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Calming Aids for Dogs Production Mode & Process Analysis
7.4 Calming Aids for Dogs Sales and Marketing
7.4.1 Calming Aids for Dogs Sales Channels
7.4.2 Calming Aids for Dogs Distributors
7.5 Calming Aids for Dogs Customer Analysis
8 Calming Aids for Dogs Market Dynamics
8.1 Calming Aids for Dogs Industry Trends
8.2 Calming Aids for Dogs Market Drivers
8.3 Calming Aids for Dogs Market Challenges
8.4 Calming Aids for Dogs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Calming Aids for Dogs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Calming Aids for Dogs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Calming Aids for Dogs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Calming Aids for Dogs Sales (K Dose) of Key Manufacturers (2020-2025)
Table 5. Global Calming Aids for Dogs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Calming Aids for Dogs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Calming Aids for Dogs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Calming Aids for Dogs Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Calming Aids for Dogs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Calming Aids for Dogs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Calming Aids for Dogs, Product Type & Application
Table 12. Global Key Manufacturers of Calming Aids for Dogs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Calming Aids for Dogs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calming Aids for Dogs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Calming Aids for Dogs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Calming Aids for Dogs Sales by Region (2020-2025) & (K Dose)
Table 18. Global Calming Aids for Dogs Sales Market Share by Region (2020-2025)
Table 19. Global Calming Aids for Dogs Sales by Region (2026-2031) & (K Dose)
Table 20. Global Calming Aids for Dogs Sales Market Share by Region (2026-2031)
Table 21. Global Calming Aids for Dogs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Calming Aids for Dogs Revenue Market Share by Region (2020-2025)
Table 23. Global Calming Aids for Dogs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Calming Aids for Dogs Revenue Market Share by Region (2026-2031)
Table 25. North America Calming Aids for Dogs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Calming Aids for Dogs Sales by Country (2020-2025) & (K Dose)
Table 27. North America Calming Aids for Dogs Sales by Country (2026-2031) & (K Dose)
Table 28. North America Calming Aids for Dogs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Calming Aids for Dogs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Calming Aids for Dogs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Calming Aids for Dogs Sales by Country (2020-2025) & (K Dose)
Table 32. Europe Calming Aids for Dogs Sales by Country (2026-2031) & (K Dose)
Table 33. Europe Calming Aids for Dogs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Calming Aids for Dogs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Calming Aids for Dogs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Calming Aids for Dogs Sales by Region (2020-2025) & (K Dose)
Table 37. Asia Pacific Calming Aids for Dogs Sales by Region (2026-2031) & (K Dose)
Table 38. Asia Pacific Calming Aids for Dogs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Calming Aids for Dogs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Calming Aids for Dogs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Calming Aids for Dogs Sales by Country (2020-2025) & (K Dose)
Table 42. Latin America Calming Aids for Dogs Sales by Country (2026-2031) & (K Dose)
Table 43. Latin America Calming Aids for Dogs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Calming Aids for Dogs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Calming Aids for Dogs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Calming Aids for Dogs Sales by Country (2020-2025) & (K Dose)
Table 47. Middle East and Africa Calming Aids for Dogs Sales by Country (2026-2031) & (K Dose)
Table 48. Middle East and Africa Calming Aids for Dogs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Calming Aids for Dogs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Calming Aids for Dogs Sales (K Dose) by Type (2020-2025)
Table 51. Global Calming Aids for Dogs Sales (K Dose) by Type (2026-2031)
Table 52. Global Calming Aids for Dogs Sales Market Share by Type (2020-2025)
Table 53. Global Calming Aids for Dogs Sales Market Share by Type (2026-2031)
Table 54. Global Calming Aids for Dogs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Calming Aids for Dogs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Calming Aids for Dogs Revenue Market Share by Type (2020-2025)
Table 57. Global Calming Aids for Dogs Revenue Market Share by Type (2026-2031)
Table 58. Global Calming Aids for Dogs Price (US$/Dose) by Type (2020-2025)
Table 59. Global Calming Aids for Dogs Price (US$/Dose) by Type (2026-2031)
Table 60. Global Calming Aids for Dogs Sales (K Dose) by Application (2020-2025)
Table 61. Global Calming Aids for Dogs Sales (K Dose) by Application (2026-2031)
Table 62. Global Calming Aids for Dogs Sales Market Share by Application (2020-2025)
Table 63. Global Calming Aids for Dogs Sales Market Share by Application (2026-2031)
Table 64. Global Calming Aids for Dogs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Calming Aids for Dogs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Calming Aids for Dogs Revenue Market Share by Application (2020-2025)
Table 67. Global Calming Aids for Dogs Revenue Market Share by Application (2026-2031)
Table 68. Global Calming Aids for Dogs Price (US$/Dose) by Application (2020-2025)
Table 69. Global Calming Aids for Dogs Price (US$/Dose) by Application (2026-2031)
Table 70. VetriScience Company Information
Table 71. VetriScience Description and Business Overview
Table 72. VetriScience Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. VetriScience Calming Aids for Dogs Product
Table 74. VetriScience Recent Developments/Updates
Table 75. H&H Group Company Information
Table 76. H&H Group Description and Business Overview
Table 77. H&H Group Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. H&H Group Calming Aids for Dogs Product
Table 79. H&H Group Recent Developments/Updates
Table 80. Vetoquinol Company Information
Table 81. Vetoquinol Description and Business Overview
Table 82. Vetoquinol Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Vetoquinol Calming Aids for Dogs Product
Table 84. Vetoquinol Recent Developments/Updates
Table 85. ThunderEase Company Information
Table 86. ThunderEase Description and Business Overview
Table 87. ThunderEase Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. ThunderEase Calming Aids for Dogs Product
Table 89. ThunderEase Recent Developments/Updates
Table 90. Maxxidog Company Information
Table 91. Maxxidog Description and Business Overview
Table 92. Maxxidog Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Maxxidog Calming Aids for Dogs Product
Table 94. Maxxidog Recent Developments/Updates
Table 95. Heavenly Hounds Company Information
Table 96. Heavenly Hounds Description and Business Overview
Table 97. Heavenly Hounds Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. Heavenly Hounds Calming Aids for Dogs Product
Table 99. Heavenly Hounds Recent Developments/Updates
Table 100. ElleVet Sciences Company Information
Table 101. ElleVet Sciences Description and Business Overview
Table 102. ElleVet Sciences Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. ElleVet Sciences Calming Aids for Dogs Product
Table 104. ElleVet Sciences Recent Developments/Updates
Table 105. Wild One Company Information
Table 106. Wild One Description and Business Overview
Table 107. Wild One Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. Wild One Calming Aids for Dogs Product
Table 109. Wild One Recent Developments/Updates
Table 110. FOMO Bones Company Information
Table 111. FOMO Bones Description and Business Overview
Table 112. FOMO Bones Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. FOMO Bones Calming Aids for Dogs Product
Table 114. FOMO Bones Recent Developments/Updates
Table 115. Ark Naturals Company Information
Table 116. Ark Naturals Description and Business Overview
Table 117. Ark Naturals Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Ark Naturals Calming Aids for Dogs Product
Table 119. Ark Naturals Recent Developments/Updates
Table 120. Purina Company Information
Table 121. Purina Description and Business Overview
Table 122. Purina Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. Purina Calming Aids for Dogs Product
Table 124. Purina Recent Developments/Updates
Table 125. Kradle Company Information
Table 126. Kradle Description and Business Overview
Table 127. Kradle Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. Kradle Calming Aids for Dogs Product
Table 129. Kradle Recent Developments/Updates
Table 130. Zoetis Company Information
Table 131. Zoetis Description and Business Overview
Table 132. Zoetis Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. Zoetis Calming Aids for Dogs Product
Table 134. Zoetis Recent Developments/Updates
Table 135. Pet Remedy Company Information
Table 136. Pet Remedy Description and Business Overview
Table 137. Pet Remedy Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 138. Pet Remedy Calming Aids for Dogs Product
Table 139. Pet Remedy Recent Developments/Updates
Table 140. Ceva Company Information
Table 141. Ceva Description and Business Overview
Table 142. Ceva Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 143. Ceva Calming Aids for Dogs Product
Table 144. Ceva Recent Developments/Updates
Table 145. Adaptil Company Information
Table 146. Adaptil Description and Business Overview
Table 147. Adaptil Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 148. Adaptil Calming Aids for Dogs Product
Table 149. Adaptil Recent Developments/Updates
Table 150. Primo Pup Company Information
Table 151. Primo Pup Description and Business Overview
Table 152. Primo Pup Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 153. Primo Pup Calming Aids for Dogs Product
Table 154. Primo Pup Recent Developments/Updates
Table 155. Penelope's Bloom Company Information
Table 156. Penelope's Bloom Description and Business Overview
Table 157. Penelope's Bloom Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 158. Penelope's Bloom Calming Aids for Dogs Product
Table 159. Penelope's Bloom Recent Developments/Updates
Table 160. Extract Labs Company Information
Table 161. Extract Labs Description and Business Overview
Table 162. Extract Labs Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 163. Extract Labs Calming Aids for Dogs Product
Table 164. Extract Labs Recent Developments/Updates
Table 165. Koi CBD Company Information
Table 166. Koi CBD Description and Business Overview
Table 167. Koi CBD Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 168. Koi CBD Calming Aids for Dogs Product
Table 169. Koi CBD Recent Developments/Updates
Table 170. Elanco Company Information
Table 171. Elanco Description and Business Overview
Table 172. Elanco Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 173. Elanco Calming Aids for Dogs Product
Table 174. Elanco Recent Developments/Updates
Table 175. Zatural Company Information
Table 176. Zatural Description and Business Overview
Table 177. Zatural Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 178. Zatural Calming Aids for Dogs Product
Table 179. Zatural Recent Developments/Updates
Table 180. The Anxious Pet Company Information
Table 181. The Anxious Pet Description and Business Overview
Table 182. The Anxious Pet Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 183. The Anxious Pet Calming Aids for Dogs Product
Table 184. The Anxious Pet Recent Developments/Updates
Table 185. This Dog's Life Company Information
Table 186. This Dog's Life Description and Business Overview
Table 187. This Dog's Life Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 188. This Dog's Life Calming Aids for Dogs Product
Table 189. This Dog's Life Recent Developments/Updates
Table 190. NaturVet Company Information
Table 191. NaturVet Description and Business Overview
Table 192. NaturVet Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 193. NaturVet Calming Aids for Dogs Product
Table 194. NaturVet Recent Developments/Updates
Table 195. King Kanine Company Information
Table 196. King Kanine Description and Business Overview
Table 197. King Kanine Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 198. King Kanine Calming Aids for Dogs Product
Table 199. King Kanine Recent Developments/Updates
Table 200. Dr. Harvey’s Company Information
Table 201. Dr. Harvey’s Description and Business Overview
Table 202. Dr. Harvey’s Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 203. Dr. Harvey’s Calming Aids for Dogs Product
Table 204. Dr. Harvey’s Recent Developments/Updates
Table 205. PetHonesty Company Information
Table 206. PetHonesty Description and Business Overview
Table 207. PetHonesty Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 208. PetHonesty Calming Aids for Dogs Product
Table 209. PetHonesty Recent Developments/Updates
Table 210. Merck Animal Health Company Information
Table 211. Merck Animal Health Description and Business Overview
Table 212. Merck Animal Health Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 213. Merck Animal Health Calming Aids for Dogs Product
Table 214. Merck Animal Health Recent Developments/Updates
Table 215. Boehringer Ingelheim Company Information
Table 216. Boehringer Ingelheim Description and Business Overview
Table 217. Boehringer Ingelheim Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 218. Boehringer Ingelheim Calming Aids for Dogs Product
Table 219. Boehringer Ingelheim Recent Developments/Updates
Table 220. Shangrao Chunyu Technology Company Information
Table 221. Shangrao Chunyu Technology Description and Business Overview
Table 222. Shangrao Chunyu Technology Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 223. Shangrao Chunyu Technology Calming Aids for Dogs Product
Table 224. Shangrao Chunyu Technology Recent Developments/Updates
Table 225. Shandong Youmi Le Health Technology Company Information
Table 226. Shandong Youmi Le Health Technology Description and Business Overview
Table 227. Shandong Youmi Le Health Technology Calming Aids for Dogs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 228. Shandong Youmi Le Health Technology Calming Aids for Dogs Product
Table 229. Shandong Youmi Le Health Technology Recent Developments/Updates
Table 230. Key Raw Materials Lists
Table 231. Raw Materials Key Suppliers Lists
Table 232. Calming Aids for Dogs Distributors List
Table 233. Calming Aids for Dogs Customers List
Table 234. Calming Aids for Dogs Market Trends
Table 235. Calming Aids for Dogs Market Drivers
Table 236. Calming Aids for Dogs Market Challenges
Table 237. Calming Aids for Dogs Market Restraints
Table 238. Research Programs/Design for This Report
Table 239. Key Data Information from Secondary Sources
Table 240. Key Data Information from Primary Sources
Table 241. Authors List of This Report
List of Figures
Figure 1. Product Picture of Calming Aids for Dogs
Figure 2. Global Calming Aids for Dogs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Calming Aids for Dogs Market Share by Type: 2024 & 2031
Figure 4. Calming Supplements Product Picture
Figure 5. Pheromone Sprays Product Picture
Figure 6. Calming Collars Product Picture
Figure 7. Anxiety Vests Product Picture
Figure 8. Global Calming Aids for Dogs Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Calming Aids for Dogs Market Share by Application: 2024 & 2031
Figure 10. Household
Figure 11. Pet Hospitals and Clinics
Figure 12. Pet Shop
Figure 13. Others
Figure 14. Global Calming Aids for Dogs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Calming Aids for Dogs Market Size (2020-2031) & (US$ Million)
Figure 16. Global Calming Aids for Dogs Sales (2020-2031) & (K Dose)
Figure 17. Global Calming Aids for Dogs Average Price (US$/Dose) & (2020-2031)
Figure 18. Calming Aids for Dogs Report Years Considered
Figure 19. Calming Aids for Dogs Sales Share by Manufacturers in 2024
Figure 20. Global Calming Aids for Dogs Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Calming Aids for Dogs Players: Market Share by Revenue in Calming Aids for Dogs in 2024
Figure 22. Calming Aids for Dogs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Calming Aids for Dogs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Calming Aids for Dogs Sales Market Share by Country (2020-2031)
Figure 25. North America Calming Aids for Dogs Revenue Market Share by Country (2020-2031)
Figure 26. United States Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Calming Aids for Dogs Sales Market Share by Country (2020-2031)
Figure 29. Europe Calming Aids for Dogs Revenue Market Share by Country (2020-2031)
Figure 30. Germany Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Calming Aids for Dogs Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Calming Aids for Dogs Revenue Market Share by Region (2020-2031)
Figure 37. China Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Calming Aids for Dogs Sales Market Share by Country (2020-2031)
Figure 45. Latin America Calming Aids for Dogs Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Calming Aids for Dogs Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Calming Aids for Dogs Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Calming Aids for Dogs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Calming Aids for Dogs by Type (2020-2031)
Figure 55. Global Revenue Market Share of Calming Aids for Dogs by Type (2020-2031)
Figure 56. Global Calming Aids for Dogs Price (US$/Dose) by Type (2020-2031)
Figure 57. Global Sales Market Share of Calming Aids for Dogs by Application (2020-2031)
Figure 58. Global Revenue Market Share of Calming Aids for Dogs by Application (2020-2031)
Figure 59. Global Calming Aids for Dogs Price (US$/Dose) by Application (2020-2031)
Figure 60. Calming Aids for Dogs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
